Corrigendum to "A consensus introduction to serum replacements and serum-free media for cellular therapies" [Cytotherapy 19 (2017) 155-169]

Cytotherapy. 2018 Feb;20(2):271. doi: 10.1016/j.jcyt.2017.11.007. Epub 2017 Dec 6.

¹ Karnieli Ltd and ATVIO Biotech, Tivon, Israel. Electronic address: ohad.karnieli@gmail.com.
² Pluristem Therapeutics, Matam Park, Haifa, Israel.
³ Regenerative Medicine Clinical Center, Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
⁴ Hematology Branch, National Heart, Lung, and Blood Institute, National Institute of Health, Bethesda, Maryland, USA.
⁵ Cell Therapy Research & Technology LonzaWalkersville, Walkersville, Maryland, USA.
⁶ Biological Industries Ltd., Beit Haemek, Israel.
⁷ GE Healthcare Cell Therapy Division, Marlborough, Massachusetts, USA.
⁸ Bioprocessing Technology Institute, Singapore.
⁹ Stimlabs, Roswell, Georgia, USA.
¹⁰ Irvine Scientific, Santa Ana, California, USA.
¹¹ Karnieli Ltd and ATVIO Biotech, Tivon, Israel.

No abstract available

Publication types